{"id":19457,"date":"2021-12-21T14:20:54","date_gmt":"2021-12-21T13:20:54","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=19457"},"modified":"2021-12-21T14:20:58","modified_gmt":"2021-12-21T13:20:58","slug":"hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/","title":{"rendered":"Hybrid conference:  6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France"},"content":{"rendered":"\n<p>UNDER THE HIGH PATRONAGE OF<br>MR. EMMANUEL MACRON<br>PRESIDENT OF THE FRENCH REPUBLIC<\/p>\n\n\n\n<p>Under the patronage of<br>Mr. Olivier VERAN<br>Minister for Solidarity and Health<\/p>\n\n\n\n<p><a href=\"https:\/\/toulouse.tbvaccinesforum.org\/about\/\" target=\"_blank\" rel=\"noreferrer noopener\">The Global Forum on TB Vaccines<\/a> is the world&#8217;s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&amp;D, with the end goal of developing and deploying new TB vaccines as quickly as possible.<\/p>\n\n\n\n<p>The 6th Global Forum program will include plenary sessions, oral abstract sessions, and poster sessions covering the full range of TB vaccine research and development. A hybrid program is being planned, with options for in-person and online participation. The experience will be tailored for each audience, and programs for both in-person and online participation will be published as information is available.<\/p>\n\n\n\n<p><a href=\"https:\/\/tbvaccinesforum.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a>&nbsp;to view the program and presentations from the Virtual Global Forum on TB Vaccines (April 2021)<\/p>\n\n\n\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0264410X21011543\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a>&nbsp;to read the meeting report from the Virtual Global Forum on TB Vaccines, published in&nbsp;<em>Vaccine.<\/em><\/p>\n\n\n\n<p><a href=\"https:\/\/a7l.625.myftpupload.com\/program\/\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a>&nbsp;to view the program and presentations from the 5th Global Forum on TB Vaccines (Feburary 2018)<\/p>\n\n\n\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1472979218303408?via%3Dihub\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a>&nbsp;to read the meeting report from the 5th Global Forum.<\/p>\n\n\n\n<p>PRELIMINARY AGENDA<\/p>\n\n\n\n<p><em>This is a preliminary agenda and is subject to change. This agenda is for the in-person component. All plenary sessions will be live-streamed to the virtual platform. The full virtual program will be announced shortly.<\/em><\/p>\n\n\n\n<p><em>All times are Central European Time (UTC+1).&nbsp;<a href=\"https:\/\/timeanddate.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a>&nbsp;to convert to your local time zone.<\/em><\/p>\n\n\n\n<p><a href=\"https:\/\/toulouse.tbvaccinesforum.org\/wp-content\/uploads\/2021\/12\/Program-at-a-Glance_16-Dec-2021.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download<\/a>\u00a0the program-at-a-glance<\/p>\n\n\n\n<p>Registration <a href=\"https:\/\/toulouse.tbvaccinesforum.org\/register\/\" target=\"_blank\" rel=\"noreferrer noopener\">on this link<\/a>.<\/p>\n\n\n\n<p>Contact the organizers <a href=\"https:\/\/toulouse.tbvaccinesforum.org\/contact\/\" target=\"_blank\" rel=\"noreferrer noopener\">on this page<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UNDER THE HIGH PATRONAGE OFMR. EMMANUEL MACRONPRESIDENT OF THE FRENCH REPUBLIC Under the patronage ofMr. Olivier VERANMinister for Solidarity and Health The Global Forum on TB Vaccines is the world&#8217;s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":19467,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[35],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-21T13:20:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-21T13:20:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png\" \/>\n\t<meta property=\"og:image:width\" content=\"918\" \/>\n\t<meta property=\"og:image:height\" content=\"513\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France\",\"datePublished\":\"2021-12-21T13:20:54+00:00\",\"dateModified\":\"2021-12-21T13:20:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\"},\"wordCount\":298,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png\",\"articleSection\":[\"Ev\u00e8nements &amp; Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\",\"name\":\"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png\",\"datePublished\":\"2021-12-21T13:20:54+00:00\",\"dateModified\":\"2021-12-21T13:20:58+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png\",\"width\":918,\"height\":513,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ev\u00e8nements &amp; Colloques\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/","og_locale":"fr_FR","og_type":"article","og_title":"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-12-21T13:20:54+00:00","article_modified_time":"2021-12-21T13:20:58+00:00","og_image":[{"width":918,"height":513,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png","type":"image\/png"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France","datePublished":"2021-12-21T13:20:54+00:00","dateModified":"2021-12-21T13:20:58+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/"},"wordCount":298,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png","articleSection":["Ev\u00e8nements &amp; Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/","name":"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png","datePublished":"2021-12-21T13:20:54+00:00","dateModified":"2021-12-21T13:20:58+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/Toulouse.png","width":918,"height":513,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/hybrid-conference-6th-global-forum-on-tb-vaccines-22-24-february-2022-toulouse-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Ev\u00e8nements &amp; Colloques","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/"},{"@type":"ListItem","position":4,"name":"Hybrid conference: 6th Global Forum on TB Vaccines, 22- 24 February 2022, Toulouse, France"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 19:43:36","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/19457"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=19457"}],"version-history":[{"count":15,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/19457\/revisions"}],"predecessor-version":[{"id":19491,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/19457\/revisions\/19491"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/19467"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=19457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=19457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=19457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}